Collaboration provides a solution for a more in-depth analysis of cancer biomarkers BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Mar. 14, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and the leader in data-driven medicine, is partnering with
